Company / Capital Returned to Shareholders per Share
Roivant Sciences Capital Returned to Shareholders per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$1.60
FY2024
5-year range
$0.00 / $1.60
FY2023-FY2024
Trend
-
vs FY2023
Sector context
#20 of 51
Health Care
What the data says
At $1.60, Roivant Sciences's capital returned to shareholders per share ranks #20 of 51 in the Health Care sector.
Based on SEC 10-K filings.
1.60 in FY2024.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#20 of 51 in Health CareTop 39% of 51This company $1.60 Sector average $2.74
▼
-41.4% below sector average
Key checks
Key Insights
- Ranks #20 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.60 | - |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026